Jupiter Wellness Inc.

10/19/2021 | Press release | Distributed by Public on 10/19/2021 06:40

Jupiter Wellness Announces First Patient Dosing for Double-Blinded Placebo Controlled Trial of JW-300 for the Treatment of First Degree Burns